Oxidative stress in heart failure. More than just damage

European Heart Journal

Volumn 24, Issue 24, 2003, Pages 2161-2163

  Grieve, David J ^a   Shah, Ajay M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALLOPURINOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE;

ACUTE HEART INFARCTION; ANTIOXIDANT ACTIVITY; CAUSE OF DEATH; CELL METABOLISM; CLINICAL TRIAL; CORRELATION ANALYSIS; EDITORIAL; ENZYME ACTIVATION; ENZYME INACTIVATION; HEART DILATATION; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE REMODELING; HUMAN; MORBIDITY; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

CHRONIC DISEASE; ENZYME ACTIVATION; HEART FAILURE, CONGESTIVE; HUMANS; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; PROGNOSIS; REACTIVE OXYGEN SPECIES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0346328578     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.10.015     Document Type: Editorial

References (11)

1. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002;90:520-30.
2. Finkel T. Signal transduction by reactive oxygen species in nonphagocytic cells. J Leukoc Biol 1999;65:337-40.
3. Kameda K, Matsunaga T, Abe N et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease: possible role for left ventricular remodeling. Eur Heart J 2003;24:2180-85.
4. Byrne JA, Grieve DJ, Cave AC et al. Oxidative stress and heart failure. Arch Mal Coeur 2003;96:214-21.
5. Kinusawa S, Tsutsui H, Hayashidani S et al. Treatment with dimethylthiourea prevents left ventricular remodelling and failure after experimental myocardial infarction in mice: Role of oxidative stress. Circ Res 2000;87:392-8.
6. Moorhouse PC, Grootveld M, Halliwell B et al. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987;213:23-8.
7. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase; role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
8. Li J-M, Gall NP, Grieve DJ et al. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002;40:477-84.
9. Heymes C, Bendall JK, Ratajczak P et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 2003;41:2164-71.
10. Maack C, Kartes T, Kilter H et al. Oxygen free radical release in human failing myocardium is associated with increased activity of Racl-GTPase and represents a target for statin treatment. Circulation 2003;108:1567-74.
11. phox containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy. Circulation 2002;105:293-6.